Rocha, Gustavo Henrique Oliveira da 
; Silva, Marina de Paula; Broering, Milena Fronza; Scharf, Pablo Rhasan dos Santos ; Matsuyama, Larissa Satiko Alcântara Sekimoto ; Maria-Engler, Silvya Stuchi ; Farsky, Sandra Helena Poliselli
Source: Frontiers in Pharmacology. Unidade: FCF
Subjects: COLITE, MACRÓFAGOS, ANTIDIABÉTICOS (HIPOGLICEMIANTES)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Gustavo Henrique Oliveira da et al. Pioglitazone-mediated attenuation of experimental colitis relies on cleaving of annexin A1 released by macrophages. Frontiers in Pharmacology, v. 11, p. 1-19 art. 591561, 2020Tradução . . Disponível em: https://doi.org/10.3389/fphar.2020.591561. Acesso em: 17 nov. 2024.APA
Rocha, G. H. O. da, Silva, M. de P., Broering, M. F., Scharf, P. R. dos S., Matsuyama, L. S. A. S., Maria-Engler, S. S., & Farsky, S. H. P. (2020). Pioglitazone-mediated attenuation of experimental colitis relies on cleaving of annexin A1 released by macrophages. Frontiers in Pharmacology, 11, 1-19 art. 591561. doi:10.3389/fphar.2020.591561NLM
Rocha GHO da, Silva M de P, Broering MF, Scharf PR dos S, Matsuyama LSAS, Maria-Engler SS, Farsky SHP. Pioglitazone-mediated attenuation of experimental colitis relies on cleaving of annexin A1 released by macrophages [Internet]. Frontiers in Pharmacology. 2020 ; 11 1-19 art. 591561.[citado 2024 nov. 17 ] Available from: https://doi.org/10.3389/fphar.2020.591561Vancouver
Rocha GHO da, Silva M de P, Broering MF, Scharf PR dos S, Matsuyama LSAS, Maria-Engler SS, Farsky SHP. Pioglitazone-mediated attenuation of experimental colitis relies on cleaving of annexin A1 released by macrophages [Internet]. Frontiers in Pharmacology. 2020 ; 11 1-19 art. 591561.[citado 2024 nov. 17 ] Available from: https://doi.org/10.3389/fphar.2020.591561
